Procalcitonin as a marker for the early diagnosis of severe infection after thermal injury

被引:45
作者
Sachse, C
Machens, HG
Felmerer, G
Berger, A
Henkel, E
机构
[1] Hannover Med Sch, Dept Clin Chem 2, D-3000 Hannover, Germany
[2] Hannover Med Sch, Clin Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany
来源
JOURNAL OF BURN CARE & REHABILITATION | 1999年 / 20卷 / 05期
关键词
D O I
10.1097/00004630-199909000-00004
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
High serum concentrations of procalcitonin (PCT) the 116 amino acid precursor protein of the hormone calcitonin, have been found in patients with various bacterial infections, particularly in those with sepsis. Because recent reports have shown that serum PCT constitutes a useful parameter for the diagnosis of sepsis in patients with several clinical conditions, a temporal analysis of the PCT concentrations in the plasma of 19 patients with severe burns (median body surface area burned, 32%) was conducted retrospectively. Nine patients were classified as septic on the basis of standardized clinical and laboratory parameters, Compared with the nonseptic group, these patients showed higher plasma PCT throughout the study period (median concentrations of septic vs nonseptic patient groups: 0.4 vs 0.2 mu g/L on postburn day 2; 1.0 vs 0.3 mu g/L on postburn day 4; 5.5 vs 0.3 mu g/Z on postburn day 7; 10.8 vs 0.5 mu g/L on postburn day 9; 4.2 vs 0.4 mu g/L on postburn day 12; and 1.7 vs 0.5 mu g/L on postburn day 14), with differences considered to be significant (P < .05) from day 7 on. In contrast, differences in the plasma C-reactive protein concentrations were less pronounced and never reached statistical significance. PCT concentrations exceeding 15 mu g/L were only observed in the 3 patients who died of sepsis-induced multiple organ failure. In addition to absolute PCT, individual time courses were also of diagnostic value. PCT is a highly efficient laboratory parameter for the diagnosis of severe infectious complications after a burn injury.
引用
收藏
页码:354 / 360
页数:7
相关论文
共 27 条
[1]  
Al-Nawas B, 1996, Eur J Med Res, V1, P331
[2]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[3]  
BRUNKHORST FM, 1995, CHIR GASTROENTERO S2, V11, P42
[4]   Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF alpha and endotoxin levels early after thermal injury [J].
Carsin, H ;
Assicot, M ;
Feger, F ;
Roy, O ;
Pennacino, I ;
LeBever, H ;
Ainaud, P ;
Bohuon, C .
BURNS, 1997, 23 (03) :218-224
[5]   Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates [J].
Chiesa, C ;
Panero, A ;
Rossi, N ;
Stegagno, M ;
De Giusti, M ;
Osborn, JF ;
Pacifico, L .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (03) :664-672
[6]   PROCALCITONIN INCREASE AFTER ENDOTOXIN INJECTION IN NORMAL SUBJECTS [J].
DANDONA, P ;
NIX, D ;
WILSON, MF ;
ALJADA, A ;
LOVE, J ;
ASSICOT, M ;
BOHUON, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1605-1608
[7]   Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia [J].
deWerra, I ;
Jaccard, C ;
Corradin, SB ;
Chiolero, R ;
Yersin, B ;
Gallati, H ;
Assicot, M ;
Bohuon, C ;
Baumgartner, JD ;
Glauser, MP ;
Heumann, D .
CRITICAL CARE MEDICINE, 1997, 25 (04) :607-613
[8]   Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection [J].
Eberhard, OK ;
Haubitz, M ;
Brunkhorst, FM ;
Kliem, V ;
Koch, KM ;
Brunkhorst, R .
ARTHRITIS AND RHEUMATISM, 1997, 40 (07) :1250-1256
[9]  
ERTEL W, 1993, UNFALLCHIRURG, V96, P200
[10]   Measurement of procalcitonin levels in children with bacterial or viral meningitis [J].
Gendrel, D ;
Raymond, J ;
Assicot, M ;
Moulin, F ;
Iniguez, JL ;
Lebon, P ;
Bohuon, C .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (06) :1240-1242